183 related articles for article (PubMed ID: 21504498)
21. Conduction block in acute motor axonal neuropathy.
Kokubun N; Nishibayashi M; Uncini A; Odaka M; Hirata K; Yuki N
Brain; 2010 Oct; 133(10):2897-908. PubMed ID: 20855419
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases.
Vallat JM; Tabaraud F; Magy L; Torny F; Bernet-Bernady P; Macian F; Couratier P
Muscle Nerve; 2003 Apr; 27(4):478-85. PubMed ID: 12661050
[TBL] [Abstract][Full Text] [Related]
23. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
Kuwabara S; Yuki N; Koga M; Hattori T; Matsuura D; Miyake M; Noda M
Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA; Allen D; Makowska A; Gregson NA
J Peripher Nerv Syst; 2006 Mar; 11(1):30-46. PubMed ID: 16519780
[TBL] [Abstract][Full Text] [Related]
25. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
[TBL] [Abstract][Full Text] [Related]
26. [Effector mechanisms of PNS demyelination in Gal-C induced-EAN].
Saida K
Rinsho Shinkeigaku; 1990 Dec; 30(12):1361-3. PubMed ID: 2129197
[TBL] [Abstract][Full Text] [Related]
27. Acquired inflammatory demyelinating neuropathies.
Ensrud ER; Krivickas LS
Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
[TBL] [Abstract][Full Text] [Related]
28. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.
Allen D; Giannopoulos K; Gray I; Gregson N; Makowska A; Pritchard J; Hughes RA
J Peripher Nerv Syst; 2005 Jun; 10(2):174-80. PubMed ID: 15958128
[TBL] [Abstract][Full Text] [Related]
29. Fas-mediated T-cell apoptosis in chronic inflammatory demyelinating polyneuropathy.
Comi C
J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():45-7. PubMed ID: 21696498
[TBL] [Abstract][Full Text] [Related]
30. Simulating focal demyelinating neuropathies: membrane property abnormalities.
Stephanova DI; Alexandrov AS; Kossev A; Christova L
Biol Cybern; 2007 Feb; 96(2):195-208. PubMed ID: 17072638
[TBL] [Abstract][Full Text] [Related]
31. Different profiles of onion bulb in CIDP and CMT1A in relation to extracellular matrix.
Oka N; Kawasaki T; Unuma T; Shigematsu K; Sugiyama H
Clin Neuropathol; 2013; 32(5):406-12. PubMed ID: 23458271
[TBL] [Abstract][Full Text] [Related]
32. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
[TBL] [Abstract][Full Text] [Related]
33. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
34. Nerve Pathology Distinguishes Focal Motor Chronic Inflammatory Demyelinating Polyradiculoneuropathy From Multifocal Motor Neuropathy.
Tracy JA; Taylor BV; Kiernan M; Dyck PJ; Crum BA; Mauermann ML; Amrami KK; Spinner RJ; Dyck PJB
J Clin Neuromuscul Dis; 2020 Sep; 22(1):1-10. PubMed ID: 32833719
[TBL] [Abstract][Full Text] [Related]
35. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
36. Expression of integrins in experimental autoimmune neuritis and Guillain-Barré syndrome.
Previtali SC; Archelos JJ; Hartung HP
Ann Neurol; 1998 Oct; 44(4):611-21. PubMed ID: 9778259
[TBL] [Abstract][Full Text] [Related]
37. Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies.
Kwa MS; van Schaik IN; De Jonge RR; Brand A; Kalaydjieva L; van Belzen N; Vermeulen M; Baas F
Brain; 2003 Feb; 126(Pt 2):361-75. PubMed ID: 12538403
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH
Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
[TBL] [Abstract][Full Text] [Related]
39. Molecular dissection of the myelinated axon.
Waxman SG; Ritchie JM
Ann Neurol; 1993 Feb; 33(2):121-36. PubMed ID: 7679565
[TBL] [Abstract][Full Text] [Related]
40. Pathophysiology of autoimmune polyneuropathies.
Dalakas MC
Presse Med; 2013 Jun; 42(6 Pt 2):e181-92. PubMed ID: 23642299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
